Cutting-edge basic and translational cardiovascular research: that’s Frontiers in CardioVascular Biomedicine (FCVB) 2022, a scientific congress of the European Society of Cardiology (ESC). The biennial congress of the ESC Council on Basic Cardiovascular Science (CBCS) takes place 29 April to 1 May at Semmelweis University in Budapest, Hungary. Explore the scientific programme.
Innovative research will be showcased in the scientific abstracts. Discover how genetic techniques are being investigated to limit heart muscle damage after a myocardial infarction. What are the mechanisms causing cardiovascular complications of COVID-19, and are there effective treatments for patients with long COVID? Find out in the ground-breaking abstract programme.
Don’t miss the keynote lecture from the pioneering physicist Professor Albert-László Barabási.1 The father of network biology will provide his viewpoint on the diseaseome, which examines links between healthy and diseased molecular pathways. Network medicine in cardiology will also be explored in a dedicated session.2
Professor Péter Ferdinandy, Scientific Programme co-chairperson, said: “Science now generates large quantities of data, referred to as ‘big data’. Network medicine uses novel bioinformatic and mathematical models to analyse this information and examine the connections between different diseases, which might facilitate the development of new treatments.”
Also of growing interest: how to protect the heart against multiple co-existing conditions in ageing.3 “The success of cardioprotective strategies seems to largely depend on the comorbidities of a patient,” said Professor Ferdinandy. “For example, certain diseases can change the efficacy and safety of medicines designed to prevent heart problems, making this an important consideration for drug development. These issues will be discussed at the conference along with how to maintain healthy ageing.”
“Exercise and sports may be considered as potential therapeutic interventions in various cardiovascular diseases and will be debated in two sessions,” added Professor Akos Koller, Scientific Programme co-chairperson.4,5 “These will cover how the cardiovascular system adapts to exercise and how to maintain a healthy heart with the right form of sport.”
On the flip side, inactivity is detrimental for the heart and blood vessels. Hear leaders in the field reveal new insights into how obesity and metabolic syndrome influence the development of vascular disease.6 Professor Koller said: “This is a hot topic of research since during the COVID era, many people put on weight and didn’t exercise. We have to learn more about the effect of overweight and sedentary lifestyle on vascular health, and how it can be reversed, because so far the mechanisms are not well understood.”
COVID-19 takes centre stage in two sessions examining the acute and long-term effects of infection such as blood clots.7,8 “This is a chance to hear from the scientists behind these discoveries and clarify many misconceptions,” said Professor Koller.
Other highlights in the programme include the implications of gender differences in cardiovascular disease for diagnosis, therapy and drug design;9 the potential role of gut microorganisms in atrial fibrillation and other cardiac conditions;10 and the most advanced data on heart damage caused by immune-targeted cancer therapies.11
FCVB covers the entire spectrum of basic and translational cardiovascular biomedicine. Register as press now and receive news releases from this trailblazing conference.
ENDS
Our mission: To reduce the burden of cardiovascular disease.